Why Amgen''s Cancer Drug Results Gave This Small Cap A Big Boost
Amgen stock jumped Wednesday after outperforming expectations in a lung-cancer study. It brought rival Mirati along for the ride.
Why Amgen''s Cancer Drug Results Gave This Small Cap A Big Boost
Amgen stock jumped Wednesday after outperforming expectations in a lung-cancer study. It brought rival Mirati along for the ride.